Continuation or Revision of NIDCR Clinical Trial Implementation Cooperative Agreement (UH3 Clinical Trial Required)
Key Information
Due Date: May 7, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Cooperative Agreement
Match Required: No
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
Applicants who wish to extend the duration of an ongoing clinical trial, due to the need for additional time to finish the trial or to assess long-term outcomes, can apply for a competing renewal. However, it is important that the need for extra time or longer monitoring periods be convincingly justified.
Similarly, competitive revisions to ongoing clinical trials are also welcomed. To secure this, applicants must provide a compelling justification that illustrates why changes to the scope of the ongoing trial are necessary.
Before submitting any applications for renewals or revisions to this funding opportunity, potential applicants are highly encouraged to get in touch with the respective Scientific/Research contact for the specific clinical trial they wish to renew or revise.
Key Dates
Open Date: December 1, 2021
Application Due Date: May 7, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses